Sora Neuroscience, Inc. — Form D
Sora Neuroscience, Inc. of Minneapolis, MN, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-31. The offering totals $2.0M, of which $738K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-10-31
- Form: D
- Accession: 0001437749-23-029553
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $738K
- Remaining: $1.3M
- Investors: 17
- Date of first sale: 2023-10-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-496211
Issuer
- Name: Sora Neuroscience, Inc.
- CIK: 0001882130
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4406 Beard Avenue South, Minneapolis, MN, 55410
- Phone: 612-226-2508
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Ann R Senn | Director | Minneapolis, MN |
| Stephen R Schaefer | Director | Minneapolis, MN |
| Stephen R Schaefer | Executive Officer | Minneapolis, MN |
| Stephen R Schaefer | Promoter | Minneapolis, MN |
| Tara R Butler | Director | Minneapolis, MN |
| Daniel R Marcus | Director | Minneapolis, MN |
| Eric R Leuthardt | Director | Minneapolis, MN |
Other filings by this issuer (2)
More